Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Excelsior Medical Co. Ltd. (4104:TWSE), powered by AI.
Excelsior Medical Co. Ltd. is currently trading at $69.60. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Excelsior Medical Co. Ltd. on Alpha Lenz.
View Excelsior Medical Co. Ltd.'s valuation metrics on Alpha Lenz.
“Excelsior Medical Co. Ltd.'s ROE is 8.9%. Explore profitability and growth together.”
Ask for details →Excelsior Medical Co. Ltd. is a prominent player in the healthcare and pharmaceutical sector, specializing in the research, development, and marketing of medical devices and pharmacological solutions. With a focus on innovation, the company aims to improve patient care and outcomes by providing high-quality, cost-effective medical products. Excelsior Medical's product range includes diagnostic equipment, therapeutic devices, and a variety of pharmaceutical products that address critical health needs. They serve multiple industries such as hospitals, clinics, and pharmacies, significantly contributing to the healthcare supply chain. Their commitment to research and development ensures that they remain at the forefront of technology in the medical field. By adhering to stringent quality standards, Excelsior Medical Co. Ltd. plays a crucial role in enhancing healthcare delivery systems globally. As a part of the broader healthcare ecosystem, the company’s operations and advancements not only support patient welfare but also influence healthcare practices and policies worldwide.
“Excelsior Medical Co. Ltd.'s ROE is 8.9%. Explore profitability and growth together.”
Ask for details →Excelsior Medical Co. Ltd. (ticker: 4104) is a company listed on TWSE in the Healthcare sector (Medical Distribution).
The current price is 69.6 with a P/E ratio of -x and P/B of -x.
ROE is 8.87% and operating margin is 8.25%. Annual revenue is $8.8B.